Medical technology company PAVmed has signed a nonbinding letter of intent with Durham, N.C.-based Duke University to license a multimodality endoscopic probe designed to detect and treat advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback